About Us
EN
ENCN
Clinical Cancer ResearchJournal Home
Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.
Publishing Model：Subscription
ISSN：1078-0432
|EISSN：1557-3265
|Publication Frequency：Twice monthly
|Last updated on 02 Mar 2026 / Current volume： 杚缗 / Current issue： 逦
More Details
Oncology
Impact Factor
Journal Impact Factor(JIF) 2024
声蔡.缗
Journal Citation Indicator(JCI) 2024
缗.杚炆
Web of Science Rank 2024:
鵣沟。鵣欄鵣佥巨
# 缗䟕/杚缗炆
91.26%
Q1
CiteScore Metrics
CiteScore 2024
声䟕.蔡
=
鋺杚躭杚杚 Citation （2022-2024）
缗杚声缗 Article （2022-2024）
CiteScore Rank 2024
鵣鵃桧肃⻊肃茡续
# 缗鋺/鋺声逦
94.22%
Q1
。囹鵃桧蠹㥌 葤蠹详蠹囹㥌桧㛁
# 声炆/缗杚杚
93.13%
Q1
